Elizabeth (Liz) Parrish, MBA is the Founder and CEO of BioViva Sciences USA Inc. BioViva is committed to extending healthy lifespans using gene therapy. BioViva works on combinatorial gene therapies with its proprietary CMV gene therapy delivery platform.

Liz is a humanitarian, entrepreneur, author, and innovator. She is a proponent of the Best Choice Medicine plan (BCM), a more efficient and streamlined regulatory model around the use of genetic therapies. She is actively involved in international educational media outreach and is a founding member of several 501(c)(3) nonprofits in the space. She considers aging a disease and believes the advancements in space will lead to healthier and longer lifespans with the added benefit of safer space travel and curative medicine for patients under 20.